Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), today announced that it has priced its registered underwritten public offering of $75 million of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE